2 compelling ASX 200 blue chip shares to buy in April

The S&P/ASX 200 Index (ASX: XJO) is home to a good number of shares with true blue chip status. But given the many options that investors have, it can be hard to decide which ones to include in your portfolio.

In order to narrow things down, I have picked out two blue chip ASX 200 shares which are highly rated right now. They are as follows:

The first blue chip ASX 200 share to look at is Cochlear. It is a global leader in the development, manufacture, and distribution of cochlear implantable devices for the hearing impaired.

Cochlear was impacted greatly by the pandemic, but has bounced back incredibly quickly. For example, in February the company released its half year results and revealed an underlying net profit of $125.3…